Alexandre Sudarskis

Chief Executive Officer/Managing Director

Biography >

Mr Sudarskis brings 38 years of international management experience in the pharmaceutical industry gained from Institut Merieux, MERIAL, Sanofi Pasteur, Novartis Vaccines and Viropharma. Mr. Sudarskis was formerly a member of the Executive Committee at Novartis Vaccines and served as Global Head International Business Operations, Managing Director Novartis Vaccines France, Chair of Chiron Panacea Vaccines India and Novartis Behring India. Mr Sudarskis holds a degree in Law & Economy from the University of Lyon, France.

Jürgen Pohle

Vice President and Chief Commercial Officer

Biography >

In his role, he leads the global commercial organisation for further growth and development of products. Mr Pohle joined Neovii in 2016 bringing over 25 years of experience in the pharmaceutical industry. Prior to joining Neovii, he held senior leadership positions at GSK, Novartis and Bayer HealthCare. Mr Pohle holds a law degree from University of Cologne, Germany.

Bernhard Saalfrank

Vice President Finance and Chief Financial Officer

Biography >

Mr. Saalfrank joined the company in 2014 with 15 years of experience in the pharmaceuticals and biotech industry. During this time, he worked for the leading companies such as AMGEN and Biogen, holding managerial finance positions in local as well as international settings. Mr. Saalfrank previously served as CFO EMEA for Onyx Pharmaceuticals. Mr. Saalfrank has a B.S. in Industrial Engineering from University of Munich as well as an MBA from Texas A&M University, USA.

John Petan MD

Vice President and Chief Medical Officer

Biography >

Dr Petan has 20 years experience in the pharmaceutical industry including VP of Medical and Development Division at Astellas China, Senior Director at Genzyme Europe and Director Medical Affairs at Fresenius Biotech as well as at Astellas Europe.  In addition to his medical degrees from Colombia and Germany, Dr Petan has an Executive MBA degree from the Instituto de Empresa, Spain.

Dr Christian Loss

Vice President, Managing Director & Country Head Germany

Biography >

Dr Loss leads the company’s global manufacturing operations (Neovii Biotech GmBH) and as well as commercial & development operations for Germany. Dr. Loss joined the company in 2009 from Fresenius Biotech where he served as Vice-President and Head of Business Unit. Dr. Loss has in addition worked for international, industrial and consulting companies. He holds a PhD in business economics from the University of St. Gallen, Switzerland.

Frank Glavin

Vice President and Head of North America

Biography >

In this role, he oversees the group’s strategy, clinical and commercial development, and operations for North America. Mr Glavin brings over 15 years of drug and commercial development experience in both public and private companies to Neovii. Previously he was the Director of Therapeutics at CombinatoRx where he spearheaded translational drug development. Prior to that, Mr Glavin was part of the Serono Strategic Planning team and was a Life Science Management Consultant developing new-business incubation, in-licensing and acquisition, and franchise development strategies for global pharmaceutical and health care clients. Mr Glavin has a B.S. in Human Physiology from Boston University as well as an MBA from the Johnson Graduate School of Management at Cornell University.